Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.600
-0.014 (-2.33%)
Mar 6, 2026, 11:57 AM EST - Market open
Vistagen Therapeutics Employees
Vistagen Therapeutics had 57 employees as of March 31, 2025. The number of employees increased by 17 or 42.50% compared to the previous year.
Employees
57
Change (1Y)
17
Growth (1Y)
42.50%
Revenue / Employee
$13,373
Profits / Employee
-$1,136,373
Market Cap
23.77M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Barinthus Biotherapeutics | 105 |
| IO Biotech | 78 |
| Boundless Bio | 64 |
| Passage Bio | 60 |
| Senti Biosciences | 34 |
| Skye Bioscience | 16 |
| Reviva Pharmaceuticals Holdings | 14 |
| Neuphoria Therapeutics | 8 |
VTGN News
- 1 day ago - Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, Inc. Stockholders to Contact the Firm Regarding the Upcoming March 16th Lead Plaintiff Deadline - GlobeNewsWire
- 3 days ago - Vistagen to Participate in Upcoming Investor Conferences - Business Wire
- 9 days ago - Vistagen to Participate in the 46th Annual TD Cowen Healthcare Conference - Business Wire
- 21 days ago - Vistagen Therapeutics, Inc. (VTGN) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Vistagen Reports Fiscal Year 2026 Third Quarter Financial Results and Provides Corporate Update - Business Wire
- 24 days ago - UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics - Newsfile Corp
- 4 weeks ago - VTGN Investors Encouraged to Seek Lead Plaintiff Role in Vistagen Therapeutics Securities Class Actoin Case with Johnson Fistel - GlobeNewsWire
- 4 weeks ago - Vistagen to Report Fiscal Year 2026 Third Quarter Results and Host Corporate Update Conference Call on February 12, 2026 - Business Wire